Live Breaking News & Updates on Therapeutic Area Strategy

Stay updated with breaking news from Therapeutic area strategy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

J&J: EU marketing authorization application for Rybrevant -December 22, 2023 at 09:01 am EST

Johnson & Johnson announces that it has submitted a marketing authorization application to the European Medicines Agency seeking approval of lazertinib + Rybrevant for the first-line treatment of. ....

Catherine Taylor , European Medicines Agency , Vice President Medical Affairs , Therapeutic Area Strategy ,

Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

/PRNewswire/ CSL Vifor today announced topline primary efficacy results from the pivotal Phase 3 DUPLEX Study of sparsentan, a Dual Endothelin Angiotensin. ....

Steve Pascoe , Vifor International , Fresenius Medical Care , Dual Endothelin Angiotensin Receptor Antagonist , Senior Vice President , Therapeutic Area Strategy , Efficacy Endpoints , Two Year Exploratory Endpoints , Travere Therapeutics , Vifor Fresenius Medical Care Renal Pharma , Vifor International Ag Csl ,

Vifor International AG (CSL Vifor): Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment ....

Steve Pascoe , Fresenius Medical Care , Dual Endothelin Angiotensin Receptor Antagonist , Senior Vice President , Therapeutic Area Strategy , Efficacy Endpoints , Two Year Exploratory Endpoints , Travere Therapeutics , Vifor Fresenius Medical Care Renal Pharma ,

Amy Mahery, Author at MedCity News

Amy Mahery, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Amy Mahery , Execution Leadership Team , Leadership Team , International Leadership Team , Trinity College , Diversity Council , Global Business Franchise , Therapeutic Area Strategy , Chief Marketing Officer Leadership Team ,

Europe approves Ponvory (ponesimod) for multiple sclerosis

Europe approves Ponvory (ponesimod) for multiple sclerosis
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Gavin Giovannoni , Catherine Taylor , Janssen Ponvory , European Union , European Medicines Agency , European Commission , Drug Administration , Committee For Medicinal Products Human Use , Professor Gavin Giovannoni , Queen Mary University , Vice President , Medical Affairs , Therapeutic Area Strategy , Middle East , Johnson Middle East , Alanine Aminotransferase , Medicinal Products , Human Use , European Economic Area , ஒன்றுபட்டது கிஂக்டம் , கேத்தரின் டெய்லர் , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய தரகு , குழு க்கு மருத்துவ ப்ராடக்ட்ஸ் மனிதன் பயன்பாடு , ராணி மேரி பல்கலைக்கழகம் ,